Department of Medical Microbiology,
Immunology and Cell Biology,
Department of Medical Microbiology, Immunology and Cell Biology
Andrew Wilber has not added Biography.
If you are Andrew Wilber and would like to personalize this page please email our Author Liaison for assistance.
Deoxyribonuclease I-like III is an inducible macrophage barrier to liposomal transfection.
Molecular therapy : the journal of the American Society of Gene Therapy Jul, 2002 | Pubmed ID: 12095301
A picornaviral 2A-like sequence-based tricistronic vector allowing for high-level therapeutic gene expression coupled to a dual-reporter system.
Molecular therapy : the journal of the American Society of Gene Therapy Sep, 2005 | Pubmed ID: 15964244
Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system.
Blood Jan, 2006 | Pubmed ID: 16189271
Dynamic gene expression after systemic delivery of plasmid DNA as determined by in vivo bioluminescence imaging.
Human gene therapy Nov, 2005 | Pubmed ID: 16259566
RNA as a source of transposase for Sleeping Beauty-mediated gene insertion and expression in somatic cells and tissues.
Molecular therapy : the journal of the American Society of Gene Therapy Mar, 2006 | Pubmed ID: 16368272
Conditional gene expression in the mouse using a Sleeping Beauty gene-trap transposon.
BMC biotechnology , 2006 | Pubmed ID: 16800892
Harnessing a high cargo-capacity transposon for genetic applications in vertebrates.
PLoS genetics Nov, 2006 | Pubmed ID: 17096595
Messenger RNA as a source of transposase for sleeping beauty transposon-mediated correction of hereditary tyrosinemia type I.
Molecular therapy : the journal of the American Society of Gene Therapy Jul, 2007 | Pubmed ID: 17440442
Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer.
Stem cells (Dayton, Ohio) Nov, 2007 | Pubmed ID: 17673526
A facile method for somatic, lifelong manipulation of multiple genes in the mouse liver.
Hepatology (Baltimore, Md.) May, 2008 | Pubmed ID: 18435462
Liver-directed gene therapy using the sleeping beauty transposon system.
Methods in molecular biology (Clifton, N.J.) , 2008 | Pubmed ID: 18470650
DNA transposons for modification of human primary T lymphocytes.
Methods in molecular biology (Clifton, N.J.) , 2009 | Pubmed ID: 19110623
Gene expression in lung and liver after intravenous infusion of polyethylenimine complexes of Sleeping Beauty transposons.
Human gene therapy Feb, 2010 | Pubmed ID: 19761403
Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.
Blood Jan, 2010 | Pubmed ID: 19901262
Roles of inflammation in cancer initiation, progression, and metastasis.
Frontiers in bioscience (Scholar edition) Jan, 2010 | Pubmed ID: 20036938
Cytotoxicity associated with artemis overexpression after lentiviral vector-mediated gene transfer.
Human gene therapy Jul, 2010 | Pubmed ID: 20163250
A zinc-finger transcriptional activator designed to interact with the gamma-globin gene promoters enhances fetal hemoglobin production in primary human adult erythroblasts.
Blood Apr, 2010 | Pubmed ID: 20190190
Unexpectedly high copy number of random integration but low frequency of persistent expression of the Sleeping Beauty transposase after trans delivery in primary human T cells.
Human gene therapy Nov, 2010 | Pubmed ID: 20528476
Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer.
Blood Mar, 2011 | Pubmed ID: 21156846
Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase.
Breast cancer research and treatment Nov, 2011 | Pubmed ID: 21188630
Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities.
Blood Apr, 2011 | Pubmed ID: 21321359
A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine.
PloS one Mar, 2011 | Pubmed ID: 21412438
Efficient non-viral integration and stable gene expression in multipotent adult progenitor cells.
Stem cells international , 2011 | Pubmed ID: 21977042
Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells.
Cancer research Jan, 2012 | Pubmed ID: 22113945
Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone.
The Journal of experimental medicine Dec, 2011 | Pubmed ID: 22124112
Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells.
The Biochemical journal Mar, 2012 | Pubmed ID: 22329800
Novel model for basaloid triple-negative breast cancer: behavior in vivo and response to therapy.
Neoplasia (New York, N.Y.) Oct, 2012 | Pubmed ID: 23097627
Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain.
EMBO molecular medicine Mar, 2013 | Pubmed ID: 23495140
Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells.
Experimental hematology May, 2015 | Pubmed ID: 25681747
Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells.
Blood Apr, 2015 | Pubmed ID: 25733580
A system for creating stable cell lines that express a gene of interest from a bidirectional and regulatable herpes simplex virus type 1 promoter.
PloS one , 2015 | Pubmed ID: 25823013
Partial nephrectomy for T2 renal masses: contemporary trends and oncologic efficacy.
International urology and nephrology Jun, 2015 | Pubmed ID: 25864101
Exploiting natural anti-tumor immunity for metastatic renal cell carcinoma.
Human vaccines & immunotherapeutics , 2015 | Pubmed ID: 25996049
Amelioration of murine sickle cell disease by nonablative conditioning and γ-globin gene-corrected bone marrow cells.
Molecular therapy. Methods & clinical development , 2015 | Pubmed ID: 26665131
Long noncoding RNA Saf and splicing factor 45 increase soluble Fas and resistance to apoptosis.
Oncotarget Mar, 2016 | Pubmed ID: 26885613
Fas-antisense long noncoding RNA is differentially expressed during maturation of human erythrocytes and confers resistance to Fas-mediated cell death.
Blood cells, molecules & diseases May, 2016 | Pubmed ID: 27067490
Data in support of transcriptional regulation and function of Fas-antisense long noncoding RNA during human erythropoiesis.
Data in brief Jun, 2016 | Pubmed ID: 27141526
1Department of Urology, University of Minnesota,
2Masonic Cancer Center, University of Minnesota,
3Microbiology, Immunology, and Cancer Biology Graduate Program, University of Minnesota,
4Department of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University School of Medicine,
5, Simmons Cancer Institute
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유